deferoxamine has been researched along with Deficiency, Vitamin E in 7 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Several vanadium compounds were tested for their ability to induce in vitro hemolysis of vitamin E-deficient hamster erythrocytes." | 7.69 | Vanadium induced hemolysis of vitamin E deficient erythrocytes in Hepes buffer. ( Hamada, T, 1994) |
| "Several vanadium compounds were tested for their ability to induce in vitro hemolysis of vitamin E-deficient hamster erythrocytes." | 3.69 | Vanadium induced hemolysis of vitamin E deficient erythrocytes in Hepes buffer. ( Hamada, T, 1994) |
| "Deferoxamine treatment was started simultaneously (n = 21), 6 h (n = 18), and 16 h (n = 18) after paraquat poisoning." | 1.28 | Continuous intravenous infusion of deferoxamine reduces mortality by paraquat in vitamin E-deficient rats. ( Boonen, HC; de Jong, Y; Dormans, JA; Hillen, FC; Marx, JJ; Sangster, B; van Asbeck, BS; van der Wal, NA, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, IA | 1 |
| Lin, XM | 1 |
| Waller, SB | 1 |
| Dietz, NJ | 1 |
| Hamada, T | 1 |
| Omara, FO | 1 |
| Blakley, BR | 1 |
| Tanaka, M | 1 |
| Sotomatsu, A | 1 |
| Kanai, H | 1 |
| Hirai, S | 1 |
| Kagan, VE | 1 |
| Serbinova, EA | 1 |
| Safadi, A | 1 |
| Catudioc, JD | 1 |
| Packer, L | 1 |
| van Asbeck, BS | 1 |
| Hillen, FC | 1 |
| Boonen, HC | 1 |
| de Jong, Y | 1 |
| Dormans, JA | 1 |
| van der Wal, NA | 1 |
| Marx, JJ | 1 |
| Sangster, B | 1 |
7 other studies available for deferoxamine and Deficiency, Vitamin E
| Article | Year |
|---|---|
Proposed treatment of Duchenne muscular dystrophy with desferrioxamine.
Topics: Animals; Deferoxamine; Genes, Recessive; Genetic Linkage; Humans; Iron; Membrane Lipids; Muscles; Mu | 1984 |
Effects of deferoxamine and a diet deficient in vitamin E on isoelectric electroencephalographic responses associated with ischemia by the four vessel occlusion method.
Topics: Animals; Brain; Deferoxamine; Diet; Electroencephalography; Ischemic Attack, Transient; Male; Rats; | 1995 |
Vanadium induced hemolysis of vitamin E deficient erythrocytes in Hepes buffer.
Topics: Analysis of Variance; Animals; Chelating Agents; Cricetinae; Deferoxamine; Erythrocytes; Free Radica | 1994 |
Vitamin E is protective against iron toxicity and iron-induced hepatic vitamin E depletion in mice.
Topics: Animals; Chemical and Drug Induced Liver Injury; Deferoxamine; Diet; Iron; Liver; Liver Diseases; Ma | 1993 |
Combined histochemical and biochemical demonstration of nigral vulnerability to lipid peroxidation induced by dopa and iron.
Topics: Adenosine Diphosphate; Animals; Caudate Nucleus; Deferoxamine; Dihydroxyphenylalanine; Iron; Iron Ch | 1992 |
NADPH-dependent inhibition of lipid peroxidation in rat liver microsomes.
Topics: Animals; Azo Compounds; Chromans; Chromatography, High Pressure Liquid; Deferoxamine; Kinetics; Lipi | 1992 |
Continuous intravenous infusion of deferoxamine reduces mortality by paraquat in vitamin E-deficient rats.
Topics: Animals; Deferoxamine; Escherichia coli; Infusion Pumps; Lung; Male; Mortality; Osmolar Concentratio | 1989 |